Francesca Arriaga-Filippi

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Longitudinal Changes in Body Composition, Adaptive Thermogenesis and Muscle Strength in Patients with Obesity Treated with Semaglutide.

Longitudinal Changes in Body Composition, Adaptive Thermogenesis and Muscle Strength in Patients with Obesity Treated with Semaglutide.

Journal: Obesity facts

Published: March 07, 2026

Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of Obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors.

Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of Obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors.

Journal: Journal of hypertension

Published: December 08, 2025

EASO Position Statement: Women with Obesity across the Reproductive Life - Fertility, Preconception, Pregnancy, Postpartum, and Breastfeeding.

EASO Position Statement: Women with Obesity across the Reproductive Life - Fertility, Preconception, Pregnancy, Postpartum, and Breastfeeding.

Journal: Obesity facts

Published: March 07, 2025

Key Gaps in the Prevention and Treatment of Obesity in Children and Adolescents: A Critical Appraisal of Clinical Guidelines.

Key Gaps in the Prevention and Treatment of Obesity in Children and Adolescents: A Critical Appraisal of Clinical Guidelines.

Journal: Children (Basel, Switzerland)

Published: February 07, 2025

A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience.

A cross-sectional study of Phase I Clinical Trials authorized in Spain: An analysis of characteristics and times of execution based on experience.

Journal: Medicina clinica

Published: April 03, 2024

Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk.

Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk.

Journal: Medicina clinica

Published: December 28, 2023

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system.

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system.

Journal: Frontiers in pharmacology

Published: May 02, 2023

Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve.

Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve.

Journal: European journal of clinical pharmacology

Published: November 07, 2022

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.

Journal: Frontiers in endocrinology

Published: June 27, 2021

A novel case of diabetes MODY1 and chronic hereditary pancreatitis: coexistence of two infrequent genetic mutations.

A novel case of diabetes MODY1 and chronic hereditary pancreatitis: coexistence of two infrequent genetic mutations.

Journal: Endocrinologia, diabetes y nutricion

Published: October 16, 2020

Progressive multifocal leukoencephalopathy in the era of new disease-modifying treatments for multiple sclerosis.

Progressive multifocal leukoencephalopathy in the era of new disease-modifying treatments for multiple sclerosis.

Journal: Medicina clinica

Published: July 28, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026